Home › Funds › Commodore Capital LP › PHVS

Commodore Capital LP position in PHVS

PHARVARIS N V · Health Care

Commodore Capital LP reported holding 1,425,000 shares of PHVS (PHARVARIS N V) in its Q2 2026 13F filing — a position valued at US$49.3M, representing 2.93% of its reported portfolio and ranking #14 among its reported holdings. Commodore Capital LP has disclosed PHVS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)1.43M sh
Reported value held$49.28M
Portfolio Weight2.93%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Commodore Capital LP's PHVS position evolved

Commodore Capital LP first disclosed a stake in PHVS in Q4 2023 at 800,000 shares (US$22.4M). The position peaked in Q3 2025 at 2,418,476 shares, worth US$60.3M. Across 11 filings, Commodore Capital LP increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 1,425,000 shares valued at US$49.3M — a reduction of -493,970 shares quarter over quarter.. Notable position changes include a 116% increase in Q1 2024, a 27% increase in Q3 2025 (shares rose 11% over the following quarter), a 26% trim in Q2 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 800.00K $22.44M New
Q1 2024 1.73M $39.86M Add
Q2 2024 1.81M $34.03M Add
Q3 2024 1.91M $35.40M Add
Q4 2024 1.91M $36.64M Hold
Q1 2025 1.91M $30.01M Hold
Q2 2025 1.91M $33.64M Hold
Q3 2025 2.42M $60.34M Add
Q4 2025 1.89M $52.43M Reduce
Q1 2026 1.92M $54.21M Add
Q2 2026 1.43M $49.28M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHVS and 13F data

PHVS (PHARVARIS N V) is a Health Care company. 49 other funds we track also report a position in PHVS — the largest reported positions include GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHVS

All PHVS fund holders →

FAQ

How long has Commodore Capital LP held PHVS?

Commodore Capital LP has disclosed PHVS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is Commodore Capital LP's current position in PHVS?

As of Q2 2026, Commodore Capital LP holds 1.43M shares of PHVS (PHARVARIS N V), valued at $49.28M, representing 2.93% of its reported portfolio and ranking #14.

Has Commodore Capital LP been buying or selling PHVS?

In the latest 13F filing (Q2 2026), Commodore Capital LP reduced its position in PHVS. The position peaked in Q3 2025 at 2.42M shares.

Which other funds hold PHVS?

Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, venBio Partners LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.